Supplementary Methods from Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2–Negative Advanced Breast Cancer That Progressed during or after Bevacizumab
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 65K
Authors: Lee S. Schwartzberg, Kurt W. Tauer, Robert C. Hermann, Grace Makari-Judson, Claudine Isaacs, J. Thaddeus Beck, Virginia Kaklamani, Edward J. Stepanski, Hope S. Rugo, Wei Wang, Katherine Bell-McGuinn, Jeffrey J. Kirshner, Peter Eisenberg, Richard Emanuelson, Mark Keaton, Ellis Levine, Diana C. Medgyesy, Rubina Qamar, Alexander Starr, Sunhee Kwon Ro, Nathalie A. Lokker, Clifford A. Hudis
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361904544